Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The cross-sectional and longitudinal associations of chromium with dyslipidemia: A prospective cohort study of urban adults in China.

Xiao L, Zhou Y, Ma J, Cao L, Wang B, Zhu C, Yang S, Li W, Zhang Z, Wang D, Guo Y, Mu G, Yuan J, Chen W.

Chemosphere. 2019 Jan;215:362-369. doi: 10.1016/j.chemosphere.2018.10.060. Epub 2018 Oct 10.

PMID:
30336313
2.

Association between urinary polycyclic aromatic hydrocarbon metabolites and dyslipidemias in the Chinese general population: A cross-sectional study.

Ma J, Zhou Y, Liu Y, Xiao L, Cen X, Li W, Guo Y, Kim M, Yuan J, Chen W.

Environ Pollut. 2018 Nov 1;245:89-97. doi: 10.1016/j.envpol.2018.10.134. [Epub ahead of print]

PMID:
30415036
3.

Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.

Nejat A, Mirbolouk M, Mohebi R, Hasheminia M, Tohidi M, Saadat N, Azizi F, Hadaegh F.

Clin Biochem. 2014 Sep;47(13-14):1239-44. doi: 10.1016/j.clinbiochem.2014.03.004. Epub 2014 Mar 21.

PMID:
24657509
4.

[Association between 23 urinary metals and mean platelet volume among a community-dwelling population in Wuhan, China].

Feng W, He XS, Yu YQ, Li-Gu Y, Zhang XM, Yuan J, Chen WH, Wu TC.

Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Aug 6;50(8):689-97. doi: 10.3760/cma.j.issn.0253-9624.2016.08.005. Chinese.

PMID:
27539521
5.

The correlation between serum free thyroxine and regression of dyslipidemia in adult males: A 4.5-year prospective study.

Wang H, Liu A, Zhou Y, Xiao Y, Yan Y, Zhao T, Gong X, Pang T, Fan C, Zhao J, Teng W, Shan Z, Lai Y.

Medicine (Baltimore). 2017 Sep;96(39):e8163. doi: 10.1097/MD.0000000000008163.

6.

Association between circulating full-length angiopoietin-like protein 8 and non-high-density lipoprotein cholesterol levels in Chinese non-diabetic individuals: a cross-sectional study.

Yang S, Jiao X, Huo X, Zhu M, Wang Y, Fang X, Yang Y, Yue W, Qin Y.

Lipids Health Dis. 2018 Jul 18;17(1):161. doi: 10.1186/s12944-018-0802-9.

7.

Cadmium Exposure is Associated with the Prevalence of Dyslipidemia.

Zhou Z, Lu YH, Pi HF, Gao P, Li M, Zhang L, Pei LP, Mei X, Liu L, Zhao Q, Qin QZ, Chen Y, Jiang YM, Zhang ZH, Yu ZP.

Cell Physiol Biochem. 2016;40(3-4):633-643. Epub 2016 Nov 30.

8.

Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women.

Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F.

Lipids Health Dis. 2010 Aug 17;9:85. doi: 10.1186/1476-511X-9-85.

9.

Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.

Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M.

Endocrine. 2008 Aug-Dec;34(1-3):36-51. doi: 10.1007/s12020-008-9100-z. Epub 2008 Nov 12.

PMID:
19003544
10.

Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population.

Momin M, Jia J, Fan F, Li J, Dou J, Chen D, Huo Y, Zhang Y.

Lipids Health Dis. 2017 Mar 14;16(1):54. doi: 10.1186/s12944-017-0441-6.

11.

Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.

Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, Zhao Z, Zhang Y, Wang L.

Int J Cardiol. 2018 Jun 1;260:196-203. doi: 10.1016/j.ijcard.2017.12.069. Erratum in: Int J Cardiol. 2018 May 12;:.

PMID:
29622441
12.

Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China.

Shen Y, Wang J, Wang Z, Qi T, Song W, Tang Y, Liu L, Zhang R, Lu H.

Medicine (Baltimore). 2015 Dec;94(48):e2201. doi: 10.1097/MD.0000000000002201.

13.

Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.

Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F.

Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191. Epub 2012 Jun 6.

PMID:
22674204
14.

Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.

Uçar B, Kiliç Z, Dinleyici EC, Colak O, Güneş E.

Anadolu Kardiyol Derg. 2007 Dec;7(4):415-20.

15.

Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.

Li X, Gao L, Wang Z, Guan B, Guan X, Wang B, Han X, Xiao X, Waleed KB, Chandran C, Wu S, Xia Y.

Clin Cardiol. 2018 Mar;41(3):314-320. doi: 10.1002/clc.22864. Epub 2018 Mar 25.

16.

Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study.

Liu X, Yu S, Mao Z, Li Y, Zhang H, Yang K, Zhang H, Liu R, Qian X, Li L, Bie R, Wang C.

Lipids Health Dis. 2018 May 22;17(1):119. doi: 10.1186/s12944-018-0768-7.

17.

Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.

Delacrétaz A, Vandenberghe F, Gholam-Rezaee M, Saigi Morgui N, Glatard A, Thonney J, Solida-Tozzi A, Kolly S, Gallo SF, Baumann P, Berney S, Zulauff SV, Aubry JM, Hasler R, Ebbing K, von Gunten A, Conus P, Eap CB.

J Clin Lipidol. 2018 Jan - Feb;12(1):219-229. doi: 10.1016/j.jacl.2017.10.002. Epub 2017 Oct 16.

18.

Increased Visceral Adipose Tissue Is an Independent Predictor for Future Development of Atherogenic Dyslipidemia.

Hwang YC, Fujimoto WY, Hayashi T, Kahn SE, Leonetti DL, Boyko EJ.

J Clin Endocrinol Metab. 2016 Feb;101(2):678-85. doi: 10.1210/jc.2015-3246. Epub 2015 Dec 4.

19.

Serum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese population.

Zhang L, Yuan Z, Chen W, Chen S, Liu X, Liang Y, Shao X, Zou H.

Int J Environ Res Public Health. 2014 Jul 29;11(8):7622-35. doi: 10.3390/ijerph110807622.

20.

Associations between non-traditional lipid measures and risk for type 2 diabetes mellitus in a Chinese community population: a cross-sectional study.

Song Q, Liu X, Wang A, Wang Y, Zhou Y, Zhou W, Wang X.

Lipids Health Dis. 2016 Apr 5;15:70. doi: 10.1186/s12944-016-0239-y.

Supplemental Content

Support Center